C-4. Drug Use Criteria

Acetylcholinesterase Inhibitors
Aerosolized Agents - metered-dose inhalers: anti-cholinergic drugs
Aerosolized Agents - metered-dose inhalers: anti-inflammatory drugs
Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (long-acting)
Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (short-acting)
Angiotensin II Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-depressants, oral (other)
Anti-depressants, selective serotonin reuptake inhibitors
Anti-diabetic Agents (oral)
Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder Medications
Atypical Anti-psychotics (long-acting injectable)
Atypical Anti-psychotics (oral)
Benzodiazepines (Oral, Nasal, Rectal)
Complement Inhibitor and Enzyme/Protein Replacement Therapy
Cyclooxygenase-2 Inhibitors
Direct Oral Anticoagulants
Exogenous Insulin Products
Fentanyl
Fluoroquinolones (oral)
Gabapentin
Glucagon-like Peptide 1 Receptor Agonists
Hepatitis C Direct-Acting Antivirals
Histamine H2 - Receptor Antagonists
Hydrocodone Bitartrate/Hydrocodone Polistirex
Hydroxy-Methylglutaryl Coenzyme A Reductase Inhibitors
Immune Globulins
Ivacaftor (Kalydeco) and Lumacaftor/Ivacaftor (Orkambi)
Ketorolac (oral)
Leukotriene Receptor Antagonists
Low-Molecular-Weight Heparins
Mecasermin
Memantine
Nebulized Bronchodilators
Nitazoxanide (Alinia)
Non-sedating Antihistamines
Non-steroidal anti-inflammatory drugs
Platelet Aggregation Inhibitors
Pramlintide
Promethazine Use In Children Less Than 2 Years of Age
Proton Pump Inhibitors
Quetiapine (low dose)
Rifaximin (Xifaxan)
Sedative/Hypnotics
Serotonin 5-HT1B/1D Receptor Agonists
Serotonin 5-HT3 Receptor Antagonists for Nausea and Vomiting (oral)
Sickle Cell Disease Products
Skeletal Muscle Relaxants
Substance P/Neurokinin1 Receptor Antagonists
Topical Calcineurin Inhibitors
Tramadol

Printer-friendly version